Hyperfunction Thyroid Nodules: Their Risk for Becoming or Being Associated with Thyroid Cancers

Department of Radiology, Seoul National University Hospital, Seoul 110-744, Korea.
Korean journal of radiology: official journal of the Korean Radiological Society (Impact Factor: 1.81). 07/2013; 14(4):643-52. DOI: 10.3348/kjr.2013.14.4.643
Source: PubMed

ABSTRACT To retrospectively evaluate the risk of thyroid cancer in patients with hyperfunctioning thyroid nodules through ultrasonographic-pathologic analysis.
Institutional review board approval was obtained and informed consent was waived. From 2003 to 2007, 107 patients consecutively presented with hot spots on thyroid scans and low serum thyroid-stimulating hormone levels. Among them, 32 patients who had undergone thyroid ultrasonography were analyzed in this study. Thyroid nodules depicted on ultrasonography were classified based on size and categorized as benign, indeterminate, or suspicious malignant nodules according to ultrasonographic findings. The thyroid nodules were determined as either hyperfunctioning or coexisting nodules and were then correlated with pathologic results.
In 32 patients, 42 hyperfunctioning nodules (mean number per patient, 1.31; range, 1-6) were observed on thyroid scans and 68 coexisting nodules (mean, 2.13; range, 0-7) were observed on ultrasonography. Twenty-five patients (78.1%) had at least one hyperfunctioning (n = 17, 53.1%) or coexisting (n = 16, 50.0%) nodule that showed a suspicious malignant feature larger than 5 mm (n = 8, 25.0%), or an indeterminate feature 1 cm or greater (n = 20, 62.5%) in diameter, which could have been indicated by using fine needle aspiration (FNA). Seven patients were proven to have 11 thyroid cancers in 3 hyperfunctioning and 8 coexisting nodules. All of these had at least one thyroid cancer, which could have been indicated by using FNA. The estimated minimal risk of thyroid cancer was 6.5% (7/107).
Patients with hyperfunctioning nodules may not be safe from thyroid cancer because hyperfunctioning nodules can coexist with thyroid cancer nodules. To screen out these cancers, ultrasonography should be performed.

Download full-text


Available from: Chul-Ho Sohn, Feb 11, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: The authors present the clinical and pathologic findings of 17 patients with autonomously functioning (hot) nodule of the thyroid (AFNT). The patients were 13 to 68 years of age, and 12 were female. Five had obvious laboratory findings of hyperthyroidism, but the other 12 were euthyroid. Fifteen patients had solitary or multiple benign nodules. The remaining two had autonomously functioning carcinomas; one of these patients had a papillary carcinoma with no distant metastases, and the other had a follicular carcinoma with widespread metastases. Total thyroidectomy was performed in one patient, subtotal thyroidectomy was performed in four, and hemithyroidectomy in eight. Diagnostic large needle biopsy was performed in only four patients. Of the 13 patients undergoing thyroidectomy, 3 had multiple hot nodules, and 10 had a solitary hot nodule. The size of the nodules ranged from very small to 6 cm, with no definite correlation found between the size of the nodule and thyroid function. Pathologically, cystic change and hemorrhage to various degrees were common features of AFNT. On histologic examination of the nodules, 13 were diagnosed as follicular adenoma (6 predominantly macrofollicular; 4 mixed micro-, normo-, and macrofollicular; and 3 predominantly papillary) and 2 as adenomatous goiter (1 predominantly papillary and 1 predominantly macrofollicular). The remaining two were diagnosed as carcinoma (1 follicular variant of papillary carcinoma and 1 follicular carcinoma). Two children had benign nodules showing a predominantly papillary architecture. Microcarcinoma outside the nodules was found in two patients, and both microcarcinomas were a papillary type. The AFNTs showed characteristic pathologic findings, and the pathologic differentiation of AFNTs from usually observed nonfunctioning (cold) nodules was not difficult. Pathologists should pay particular attention to AFNTs showing a papillary architecture, because these papillary lesions are sometimes mistaken for papillary thyroid carcinoma.
    American Journal of Clinical Pathology 02/1994; 101(1):29-35. · 3.01 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the framework of the Thyroid initiative Papillon 2001 - 2002 thyroid nodules and sonographically detectable focal lesions with a diameter more than 5 mm were verified in 23.1% of 64.123 persons without a history of thyroid disease. The frequency of such findings was with 33.0% in 46-65 years old persons three times higher then in persons aged 18-30 years (9.6%). In the diagnostic workup thyroid cancer was detected in 15 patients operated on up to now (6 women and 9 men; papillary cancers in 12 cases, follicular cancers in 3 cases) The smallest tumor had a diameter of 1.3 cm, the mean diameter was 2.3 +/- 91 cm. In 3 patients the tumor had invaded the tissue beyond the thyroid capsule, in 4 cases multicentric growth was detected. Lymph node metastases were found in 7/15 cases and distant metastases in 2/15 cases. These result reveal, that thyroid cancer detected by chance may be relatively aggressive. In daily routine, sonographically detectable lesions with poor echogenicity, irregular margins or internal calcifications with a diameter of more than 1 cm should be clarified by fine needle aspiration biopsy.
    Der Internist 05/2003; 44(4):412-9. · 0.27 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules are systematically developed statements to assist health care professionals in medical decision making for specific clinical conditions. Most of the content herein is based on literature reviews. In areas of uncertainty, professional judgment was applied.These guidelines are a working document that reflects the state of the field at the time of publication. Because rapid changes in this area are expected, periodic revisions are inevitable. We encourage medical professionals to use this information in conjunction with their best clinical judgment. Any decision by practitioners to apply these guidelines must be made in light of local resources and individual patient circumstances.
    Endocrine Practice 05/2010; 16 Suppl 1(Supplement 1):1-43. DOI:10.4158/10024.GL · 2.59 Impact Factor